Trial: Cll-Frail

CLL-Frail trial: efficacy & safety of acalabrutinib in elderly (≥80y) and/or frail patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

CLL Clinical Trials Explained

Patient Empowerment Network

Geriatric assessment techniques in CLL

VJHemOnc – Video Journal of Hematology & HemOnc

The CLL2-BAG trial: can CLL patients safely cease treatment after remission?

VJHemOnc – Video Journal of Hematology & HemOnc

CLL14: feasibility of fixed-duration frontline therapy in CLL

VJHemOnc – Video Journal of Hematology & HemOnc

The CLL12 trial of ibrutinib in early stage CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Clinical trials in CLL and patient support groups

Patient Power Europe

UK-based CLL clinical trials to look forward to

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Lamanna Discusses the MURANO Trial in CLL

How to treat older and frail patients with CLL?

CLL: Venetoclax in combination with obinutuzumab

VJHemOnc – Video Journal of Hematology & HemOnc

MURANO trial: Sustained disease survival in CLL following venetoclax plus rituximab

What You Should Know About CLL Clinical Trials

Patient Empowerment Network

FLAIR trial: improved outcomes with MRD-guided ibrutinib plus venetoclax in CLL compared to FCR

VJHemOnc – Video Journal of Hematology & HemOnc

First Line Treatment of CLL

What Should CLL Patients Know About Clinical Trial Treatment Options?

Patient Empowerment Network

GLOW Trial Demonstrates Favourable Outcome for Elderly CLL Patients Compared to Chemotherapy

Pirtobrutinib in CLL: updates from the BRUIN CLL-321 trial

VJHemOnc – Video Journal of Hematology & HemOnc

How Can CLL Patients Find Clinical Trials?

Patient Empowerment Network

Key BTK inhibitor trials for the initial treatment of CLL

VJHemOnc – Video Journal of Hematology & HemOnc